HOME >> BIOLOGY >> NEWS
Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Children with the bone tumor osteosarcoma are more likely to experience a recurrence of the cancer after treatment and less likely to survive if the cancer cells are expressing the telomerase gene. This finding, from investigators at St. Jude Children's Research Hospital, appears in the current issue of the Journal of Clinical Oncology (JCO).

Osteosarcoma is the most common primary bone tumor in children. Primary tumors are those originating in a specific place in the body rather than those that have spread from elsewhere. About 30 percent of children with osteosarcoma that has not spread from the bone and 60 percent of those whose tumors have spread do not survive.

"Overall, our results indicate that telomerase gene expression is associated with an unfavorable outcome for children being treated for osteosarcoma," said Jeffrey S. Dome, M.D., associate member in Hematology-Oncology at St. Jude. Dome is senior author of the JCO report. Robert P. Sanders, M.D., a St. Jude postdoctoral fellow, is the paper's first author.

Although study results are preliminary, they might lead to tests that could identify children at high risk for treatment failure or death. That could help physicians determine how to modify therapies to improve chances of success in the future. The findings were based on a retrospective study of samples taken from osteosarcoma tumors of children treated at St. Jude during a 20-year period.

Telomerase is an enzyme that helps cancer cells survive and proliferate. The enzyme builds and maintains caps called telomeres that are located on the ends of chromosomes. These telomeres protect the chromosome ends from damage that otherwise would trigger apoptosis--the cell's self-destruct program.

Most cancers activate telomerase to maintain telomeres in order to protect their chromosomes and ensure the cells survive and multiply.

However, a minority of cancers use a poorly understood mechanism called "alternativ
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
23-Sep-2004


Page: 1 2 3

Related biology news :

1. Enzyme activation appears key in helping internal clock tell night from day
2. Enzyme fully degrades mad cow disease prion
3. Enzyme revealed that is key to funguss ability to breach immune system
4. Enzyme discovery sheds light on causes of rare disease, cancer
5. Enzyme could overcome industrial bleaching waste problems
6. Enzyme controls good cholesterol
7. Enzyme discovery to benefit homeland security, industry
8. Enzyme could aid cancer fight
9. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2018)... , ... November 27, 2018 , ... ... The companies have worked together to integrate the LabArchives Classroom Edition with Current ... combined offering will be available beginning January of 2019. , The ...
(Date:11/20/2018)... ... 19, 2018 , ... Cloudponics , maker of the GroBox , ... discount of $420 for its industry-leading product during the holiday season. , Customers ... other discount and payment options available on the Cloudponics website . , ...
(Date:11/20/2018)... France (PRWEB) , ... November 20, 2018 , ... Thanks ... reaffirm its leading position on the ID reader market, as the company now proposes ... home reading, eID control, etc. Elyctis ID reader range can be used by professionals ...
Breaking Biology News(10 mins):
(Date:11/20/2018)... British Columbia (PRWEB) , ... November 19, 2018 ... ... (ISBER) is pleased to announce the release of the Chinese translation of Best ... in January 2018, is a practice-changing publication aimed at advancing the science of ...
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of ... which highlights outstanding performance by individuals under 30 years of age. The Forbes 30 ... from Sports and Entertainment to Venture Capital and Science. , In 2017, Visikol ...
(Date:11/15/2018)... ... November 14, 2018 , ... Hüpnos ... snore-reduction mask to the public. It is estimated that 90 million Americans ... themselves and their partner. The resulting daytime fatigue causes extreme difficulty with concentration, ...
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), Inc. announces ... large U.S. studies, published last week, confirm pose a significant health risk. ... (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In the AJIC ...
Breaking Biology Technology:
Cached News: